A kind of preparation method of cyclooxygenase-2 inhibitor parecoxib intermediate
A technology of parecoxib and cyclooxygenase, which is applied in the field of drug synthesis, can solve the problems of fluoride environmental pollution, complex reaction steps, and high equipment requirements, and achieve the effects of increased reaction yield, mild conditions, and simple reaction steps
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] A method for preparing a parecoxib intermediate, the method comprising: 29.1 g (100 mmol) of 1-phenyl-2-(4-sulfonic acid phenyl)-2-acetyl ethyl ketone, 30.8 g of ammonium acetate (400mmol), iodobenzene diacetate 19.3g (60mmol), potassium iodide 6.6g (40mmol) join in the flask that 150ml dichloromethane is housed, 75 ℃ carry out contact reaction 1 hour, after reaction finishes, organic phase concentration, washing, Wash with saturated brine, dry over anhydrous sodium sulfate, then recrystallize from ethanol, and dry to obtain 27.5 g of the parecoxib intermediate 5-methyl-3,4-diphenylisoxazole with a yield of 87.3% and a purity of 99.60 %.
Embodiment 2
[0023] A method for preparing parecoxib intermediate, the method comprising: 29.1g (100mmol) of 1-phenyl-2-(4-sulfonic acid phenyl)-2-acetyl ethyl ketone, 38.5g of ammonium acetate (500mmol), iodobenzene diacetate 22.5g (70mmol), potassium iodide 9.9g (60mmol) join in the flask that 150ml dichloromethane is housed, 80 ℃ carry out contact reaction 1 hour, after reaction finishes, organic phase is concentrated, washed, Washed with saturated brine, dried over anhydrous sodium sulfate, recrystallized from ethanol, and dried to obtain 27.4 g of the parecoxib intermediate 5-methyl-3,4-diphenylisoxazole with a yield of 86.8% and a purity of 99.71 %.
Embodiment 3
[0025] A method for preparing parecoxib intermediate, the method comprising: 29.1g (100mmol) of 1-phenyl-2-(4-sulfonic acid phenyl)-2-acetyl ethyl ketone, 38.5g of ammonium acetate (500mmol), iodobenzene diacetate 19.3g (60mmol), potassium iodide 6.6g (40mmol) join in the flask that 150ml dichloromethane is housed, 85 ℃ carry out contact reaction 0.5 hour, after reaction finishes, organic phase is concentrated, washed, Washed with saturated brine, dried over anhydrous sodium sulfate, then recrystallized from ethanol, and dried to obtain 26.5 g of the parecoxib intermediate 5-methyl-3,4-diphenylisoxazole with a yield of 84.5% and a purity of 99.33 %.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com